Literature DB >> 5818376

Treatment of refractory idiopathic thrombocytopenic purpura.

B A Bouroncle, C A Doan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5818376

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.

Authors:  A C Campbell; J M Skinner; I C Maclennan; P Hersey; C A Waller; J Wood; D P Jewell; S C Truelove
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

2.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.

Authors:  B Weinerman; I Maxwell; W Hryniuk
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262

4.  [Vincristin-therapy of chronic refractory idiopathic thrombocytopenic purpura (author's transl)].

Authors:  G Zeile
Journal:  Blut       Date:  1978-04-20

5.  Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland.

Authors:  Dawn Lee; Patrick Thornton; Alexander Hirst; Lucie Kutikova; Robert Deuson; Nic Brereton
Journal:  Appl Health Econ Health Policy       Date:  2013-10       Impact factor: 2.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.